Family · Pharmaceutical analytical standards
Levomepromazine
An antipsychotic of the phenothiazine family, trialled in France from 1956 and used for psychoses such as schizophrenia and the manic phases of bipolar disorder. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?Unlike most antipsychotics it also has a marked analgesic effect, besides being sedative and antiemetic: a combination that has made it valuable in palliative care.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
